Psychiatric issues in adults with sickle cell disease

Primary Psychiatry

Volumn 15, Issue 5, 2008, Pages 45-49

  Levenson, James L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

AFRICAN AMERICAN; ALCOHOL ABUSE; ANXIETY DISORDER; BRAIN INJURY; COGNITIVE DEFECT; COPING BEHAVIOR; DEPRESSION; DRUG DEPENDENCE; ECONOMIC ASPECT; HEALTH CARE DISTRIBUTION; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HUMAN; MENTAL DISEASE; MORTALITY; PAIN; PATIENT COUNSELING; PSYCHOSOCIAL CARE; QUALITY OF LIFE; REVIEW; SICKLE CELL ANEMIA; SOCIAL ASPECT; SUBSTANCE ABUSE;

EID: 43249114421     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Becker M, Axelrod DJ, Oyesanmi O, Markov DD, Kunkel EJ. Hematologic problems in psychosomatic medicine. Psychiatr Clin North Am. 2007;30(4):739-759.
2. Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal Treatment Confronting Racial and Ethnic Disparities in Health Care. 1st ed. Washington, DC: National Academies Press; 2002.
3. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639-1644.
4. Lee A, Thomas P, Cupidore L, Serjeant B, Serjeant G. Improved survival in homozygous sickle cell disease: lessons from a cohort study. BMJ. 1995;311(7020):1600-1602.
5. Gaston MH, Rosse W. The cooperative study of sickle cell disease: review of study design and objectives. Am J Pediatr Hematol Oncol. 1982;4(2):197-200.
6. Smith WR, Penberthy LT, Bovbjerg VE, et al. Daily pain in sickle cell disease. Ann Intern Med. 2008;148(2):94-101.
7. Smith WR, Bovbjerg VE, Penberthy LT, et al. Understanding pain and improving management of sickle cell disease: the PiSCES study. J Natl Med Assoc. 2005;97(2):183-193.
8. McClish DK, Penberthy LT, Bovbjerg VE, et al. Health related quality of life in sickle cell patients: the PiSCES project. Health Qual Life Outcomes. 2005;3:50.
9. McClish DK, Levenson JL, Penberthy LT, et al. Gender differences in pain and health care utilization for adult sickle cell patients: the PiSCES Project. J Womens Health (Larchmt). 2006;15(2):146-154.
10. Levenson JL, McClish DK, Dahman BA, et al. Alcohol abuse in sickle cell disease: the PiSCES project. Am J Addict. 2007;16(5):383-388.
11. Citero VA, Levenson JL, McClish DK, et al. The role of catastrophizing in sickle cell disease - the PiSCES project. Pain. 2007;133(1-3):39-46.
12. Aisiku IP, Penberthy LT, Smith WR, et al. Patient satisfaction in specialized versus nonspecialized adult sickle cell care centers: the PiSCES study. J Natl Med Assoc. 2007;99(8):886-890.
13. Levenson JL, McClish DK, Dahman BA, et al. Depression and anxiety in adults with sickle cell disease: the PiSCES project. Psychosom Med. 2008;70(2):192-196.
14. Alao AO, Cooley E. Depression and sickle cell disease. Harv Rev Psychiatry. 2001;9(4):169-177.
15. Alao AO, Dewan MJ, Jindal S, Effron M. Psychopathology in sickle cell disease. West Afr J Med. 2003;22(4):334-337.
16. Wison Schaeffer JJ, Gil KM, Burchinal M, et al. Depression, disease severity, and sickle cell disease. J Behav Med. 1999;22(2):115-126.
17. Hasan SP, Hashmi S, Alhassen M, Lawson W, Castro O. Depression in sickle cell disease. J Natl Med Assoc. 2003;95(7):533-537.
18. Laurence B, George D, Woods D. Association between elevated depressive symptoms and clinical disease severity in African-American adults with sickle cell disease. J Natl Med Assoc. 2006;98(3):365-369.
19. Molock SD, Belgrave FZ. Depression and anxiety in patients with sickle cell disease: conceptual and methodological considerations. J Health Soc Policy. 1994;5(3-4):39-53.
20. Ehigie BO. Comparative analysis of the psychological consequences of the traumatic experiences of cancer, HIV/AIDS, and sickle cell anemia patients. IFE Psychologia. 2003;11(3):34-54.
21. Scott KD, Scott AA. Cultural therapeutic awareness of sickle cell anemia. J Black Psychol. 1999;25(3):316-335.
22. Elander J, Lusher J, Bevan D, Telfer P, Burton B. Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. J Pain Symptom Manage. 2004;27(2):156-169.
23. Hurtig AL, Park KB. Adjustment and coping in adolescents with sickle cell disease. Ann N Y Acad Sci. 1989;565:172-182.
24. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325(1):11-16.
25. Brookoff O, Polomano R. Treating sickle cell pain like cancer pain. Ann Intern Med. 1992;116(5):364-368.
26. Labbe E, Herbert D, Haynes J. Physicians' attitude and practices in sickle cell disease pain management. J Palliat Care. 2005;21(4):246-251.
27. Pack-Mabien A, Labbe E, Herbert D, Haynes J Jr. Nurses' attitudes and practices in sickle cell pain management. Appl Nurs Res. 2001;14(4):187-192.
28. Shapiro BS, Benjamin LJ, Payne R, Heidrich G. Sickle cell-related pain: perceptions of medical practitioners. J Pain Symptom Manage. 1997;14(3):168-174.
29. Labbe E, Herbert D, Haynes J. Physicians' attitude and practices in sickle cell disease pain management. J Palliat Care. 2005;21(4):246-251.
30. Weissman DE, Haddox JD. Opioid pseudoaddiction - an iatrogenic syndrome. Pain. 1989;36(3):363-366.
31. Strauss A, LaCandia S. Sickle cell disease and cocaine abuse - a deadly mixture? South Med J. 1989;82(11):1455-1456.
32. Elander J, Lusher J, Bevan D, Telfer P. Pain management and symptoms of substance dependence among patients with sickle cell disease. Soc Sci Med. 2003;57(9):1683-1696.
33. Grant MM, Gil KM, Floyd MY, Abrams M. Depression and functioning in relation to health care use in sickle cell disease. Ann Behav Med. 2000;22(2):149-157.
34. Gil KM, Carson JW, Porter LS, et al. Daily stress and mood and their association with pain, healthcare use, and school activity in adolescents with sickle cell disease. J Pediatr Psychol. 2003;28(5):363-373.
35. Gil KM, Carson JW, Porter LS, Scipio C, Bediako SM, Orringer E. Daily mood and stress predict pain, health care use and work activity in African-American adults with sickle cell disease. Health Psychol. 2004;23(3):267-274.
36. Vichinsky EP, Johnson R, Lubin BH. Multidisciplinary approach to pain management in sickle cell disease. Am J Pediatr Hematol Oncol. 1982;4(3):328-333.
37. Gil KM, Carson JW, Sedway JA, Porter LS, Schaeffer JJ, Orringer E. Follow-up of coping skills training in adults with sickle cell disease: analysis of daily pain and coping practice diaries. Health Psychol. 2000;19(1):85-90.
38. Schatz J, McClellan CB. Sickle cell disease as a neurodevelopmental disorder. Ment Retard Dev Disabil Res Rev. 2006;12(3):200-207.
39. Prengler M, Pavlakis SG, Boyd S, Connelly A, Calamante F, Chong WK, Saunders D, Cox T, Bynevelt M, Lane R, Laverty A, Kirkham FJ. Sickle cell disease: ischemia and seizures. Ann Neurol. 2005;58(2):290-302.
40. Liu JE, Gzesh DJ, Ballas SK. The spectrum of epilepsy in sickle cell anemia. J Neurol Sci. 1994;123(1-2):6-10.
41. Wang WC. The pathophysiology, prevention, and treatment of stroke in sickle cell disease. Curr Opin Hematol. 2007;14(3):191-197.
42. Hariman LM, Griffith ER, Hurtig AL, Keehn MT. Functional outcomes of children with sickle-cell disease affected by stroke. Arch Phys Med Rehabil. 1991;72(7):498-502.
43. Anie KA. Psychological complications in sickle cell disease. Br J Haematol. 2005;129(6):723-729.
44. Boni LC, Brown RT, Davis PC, Hsu L, Hopkins K. Social information processing and magnetic resonance imaging in children with sickle cell disease. J Pediatr Psychol. 2001;26(5):309-319.
45. Puffer E, Schatz J, Roberts CW. The association of oral hydroxyurea therapy with improved cognitive functioning in sickle cell disease. Child Neuropsychol. 2007;13(2):142-154.